{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T04:15:25Z","timestamp":1789964125608,"version":"4.0.1"},"reference-count":124,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2019,3,6]],"date-time":"2019-03-06T00:00:00Z","timestamp":1551830400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2011-0030001"],"award-info":[{"award-number":["2011-0030001"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002551","name":"Seoul National University","doi-asserted-by":"publisher","award":["370C-20160062"],"award-info":[{"award-number":["370C-20160062"]}],"id":[{"id":"10.13039\/501100002551","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["acsjournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Cancer"],"published-print":{"date-parts":[[2019,5,15]]},"abstract":"<jats:p>The immune system represents the major primary defense line against carcinogenesis and acts by identifying and eradicating nascent transformed cells. A growing body of evidence is indicating that aberrant epigenetic reprogramming plays a key role in tumor immune escape through: 1) impaired efficient recognition of neoplastic cells by the immune system, resulting from a downregulation or loss of the expression of tumor\u2010associated antigens, human leukocyte antigens, antigen processing and presenting machinery, and costimulatory molecule genes; 2) aberrant expression of immune checkpoint proteins and their ligands; and 3) modification of cytokine profiles and tumor\u2010associated immune cell populations toward an immunosuppressive state in the tumor microenvironment. Consistent with the inherent reversibility of epigenetic alterations, epigenetic drugs, including DNA methyltransferase and histone deacetylase inhibitors, have the unique potential to favorably modify the tumor microenvironment, restore tumor recognition and stimulate an antitumor immune response. The objective of this review is to highlight selected, naturally occurring epigenetic modulators, namely, butyrate, curcumin, (\u2212)\u2010epigallocatechin\u20103\u2010gallate, resveratrol, romidepsin, and trichostatin A, with a special focus on their antitumor immune properties.<\/jats:p>","DOI":"10.1002\/cncr.32041","type":"journal-article","created":{"date-parts":[[2019,3,6]],"date-time":"2019-03-06T13:32:48Z","timestamp":1551879168000},"page":"1612-1628","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Anticancer potential of naturally occurring immunoepigenetic modulators: A promising avenue?"],"prefix":"10.1002","volume":"125","author":[{"given":"Michael","family":"Schnekenburger","sequence":"first","affiliation":[{"name":"Laboratory of Molecular and Cellular Biology of Cancer Kirchberg Hospital Luxembourg Luxembourg"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Dicato","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular and Cellular Biology of Cancer Kirchberg Hospital Luxembourg Luxembourg"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0115-4725","authenticated-orcid":false,"given":"Marc F.","family":"Diederich","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Research Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University Seoul Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2019,3,6]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2011.02.013"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-006-0164-4"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.2174\/1568026615666150825141330"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2013.12.015"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.2174\/1389202917666160803165229"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2017.07.010"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.2217\/epi.11.73"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11888-011-0116-z"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2012.02.004"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1038\/emm.2017.5"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.2174\/157340110790909581"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.2174\/1568026615666150825140822"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-016-0223-4"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-800206-3.00018-5"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-018-0765-5"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biochi.2012.05.012"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pharmtox-010716-105106"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2007.07.003"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2567.2007.02587.x"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2703"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2015.03.004"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2017.49"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-032712-100008"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18061108"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1002\/path.4832"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molonc.2011.02.001"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2017.04.012"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1521-6616(03)00200-6"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2017.05.006"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2005.08.023"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12263-012-0283-9"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2012.03.007"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biotechadv.2014.03.009"},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2014.06.005"},{"key":"e_1_2_8_36_1","doi-asserted-by":"publisher","DOI":"10.2174\/1568026615666150826114359"},{"key":"e_1_2_8_37_1","doi-asserted-by":"crossref","first-page":"15961","DOI":"10.18632\/oncotarget.14392","article-title":"Targeting microRNAs: a new action mechanism of natural compounds","volume":"8","author":"Lin Q","year":"2017","journal-title":"Oncotarget"},{"key":"e_1_2_8_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.fct.2018.10.052"},{"key":"e_1_2_8_39_1","doi-asserted-by":"publisher","DOI":"10.1080\/01635580802008278"},{"key":"e_1_2_8_40_1","doi-asserted-by":"publisher","DOI":"10.1002\/ddr.21268"},{"key":"e_1_2_8_41_1","doi-asserted-by":"publisher","DOI":"10.1002\/bies.201600200"},{"key":"e_1_2_8_42_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1026461825570"},{"key":"e_1_2_8_43_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.2289"},{"key":"e_1_2_8_44_1","doi-asserted-by":"publisher","DOI":"10.1002\/mc.20668"},{"key":"e_1_2_8_45_1","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2009.117"},{"key":"e_1_2_8_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2008.06.027"},{"key":"e_1_2_8_47_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-008-0645-8"},{"key":"e_1_2_8_48_1","doi-asserted-by":"publisher","DOI":"10.1186\/2045-3329-2-8"},{"key":"e_1_2_8_49_1","doi-asserted-by":"publisher","DOI":"10.1002\/hon.2326"},{"key":"e_1_2_8_50_1","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2017.1392426"},{"key":"e_1_2_8_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2010.07.020"},{"key":"e_1_2_8_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2013.07.028"},{"key":"e_1_2_8_53_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-016-1935-1"},{"key":"e_1_2_8_54_1","doi-asserted-by":"publisher","DOI":"10.1038\/aps.2017.179"},{"key":"e_1_2_8_55_1","doi-asserted-by":"publisher","DOI":"10.1196\/annals.1299.071"},{"key":"e_1_2_8_56_1","doi-asserted-by":"publisher","DOI":"10.1196\/annals.1329.055"},{"key":"e_1_2_8_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2004.09.041"},{"key":"e_1_2_8_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcme.2016.08.002"},{"key":"e_1_2_8_59_1","doi-asserted-by":"publisher","DOI":"10.1002\/mnfr.201300201"},{"key":"e_1_2_8_60_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.26055"},{"key":"e_1_2_8_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2008.01.008"},{"key":"e_1_2_8_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2011.04.002"},{"key":"e_1_2_8_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cdp.2005.05.003"},{"key":"e_1_2_8_64_1","doi-asserted-by":"publisher","DOI":"10.1038\/cmi.2010.11"},{"key":"e_1_2_8_65_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2012.06.016"},{"key":"e_1_2_8_66_1","first-page":"1866","article-title":"Curcumin up regulates T helper 1 cells in patients with colon cancer","volume":"9","author":"Xu B","year":"2017","journal-title":"Am J Transl Res"},{"key":"e_1_2_8_67_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.26302"},{"key":"e_1_2_8_68_1","doi-asserted-by":"publisher","DOI":"10.1158\/1940-6207.CAPR-11-0247"},{"key":"e_1_2_8_69_1","doi-asserted-by":"publisher","DOI":"10.7314\/APJCP.2015.16.9.3917"},{"key":"e_1_2_8_70_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2013.00137"},{"key":"e_1_2_8_71_1","doi-asserted-by":"publisher","DOI":"10.1158\/1940-6207.CAPR-11-0308"},{"key":"e_1_2_8_72_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.4577"},{"key":"e_1_2_8_73_1","doi-asserted-by":"publisher","DOI":"10.2217\/epi.13.57"},{"key":"e_1_2_8_74_1","doi-asserted-by":"publisher","DOI":"10.1186\/1868-7083-3-4"},{"key":"e_1_2_8_75_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2014.00170"},{"key":"e_1_2_8_76_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18102050"},{"key":"e_1_2_8_77_1","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2012.761"},{"key":"e_1_2_8_78_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-13-421"},{"key":"e_1_2_8_79_1","first-page":"627","article-title":"Epigallocatechin gallate (EGCG), influences a murine WEHI\u20103 leukemia model in vivo through enhancing phagocytosis of macrophages and populations of T\u2010 and B\u2010cells","volume":"27","author":"Huang AC","year":"2013","journal-title":"In Vivo"},{"key":"e_1_2_8_80_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jafc.6b01115"},{"key":"e_1_2_8_81_1","doi-asserted-by":"publisher","DOI":"10.1177\/039463201302600111"},{"key":"e_1_2_8_82_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-06-2638"},{"key":"e_1_2_8_83_1","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2016.00008"},{"key":"e_1_2_8_84_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19030652"},{"key":"e_1_2_8_85_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2007.12.006"},{"key":"e_1_2_8_86_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12013-015-0513-z"},{"key":"e_1_2_8_87_1","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2012.472"},{"key":"e_1_2_8_88_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2014.07.004"},{"key":"e_1_2_8_89_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2007.05.008"},{"key":"e_1_2_8_90_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1300606"},{"key":"e_1_2_8_91_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2012.12.093"},{"key":"e_1_2_8_92_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.19445"},{"key":"e_1_2_8_93_1","doi-asserted-by":"publisher","DOI":"10.4161\/cbt.19601"},{"key":"e_1_2_8_94_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-011-0971-0"},{"key":"e_1_2_8_95_1","doi-asserted-by":"publisher","DOI":"10.7164\/antibiotics.47.315"},{"key":"e_1_2_8_96_1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules21111608"},{"key":"e_1_2_8_97_1","first-page":"859","article-title":"The discovery and development of romidepsin for the treatment of T\u2010cell lymphoma","volume":"12","author":"Smolewski P","year":"2017","journal-title":"Expert Opin Drug Discov"},{"key":"e_1_2_8_98_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-05-0599"},{"key":"e_1_2_8_99_1","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2017.1341031"},{"key":"e_1_2_8_100_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0023023"},{"key":"e_1_2_8_101_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0003-4975(00)02421-8"},{"key":"e_1_2_8_102_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-15-2584"},{"key":"e_1_2_8_103_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.8379"},{"key":"e_1_2_8_104_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jid.5701216"},{"key":"e_1_2_8_105_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2017.11.004"},{"key":"e_1_2_8_106_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2009.11.078"},{"key":"e_1_2_8_107_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2012.05.031"},{"key":"e_1_2_8_108_1","doi-asserted-by":"publisher","DOI":"10.1159\/000091183"},{"key":"e_1_2_8_109_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjsurg.2015.05.028"},{"key":"e_1_2_8_110_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2006.11.022"},{"key":"e_1_2_8_111_1","doi-asserted-by":"publisher","DOI":"10.1186\/2050-7771-1-22"},{"key":"e_1_2_8_112_1","doi-asserted-by":"publisher","DOI":"10.1158\/1541-7786.MCR-05-0229"},{"key":"e_1_2_8_113_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jri.2009.02.009"},{"key":"e_1_2_8_114_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-004-0513-0"},{"key":"e_1_2_8_115_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2007.02.020"},{"key":"e_1_2_8_116_1","first-page":"349","article-title":"Trichostatin A sensitizes hepatocellular carcinoma cells to enhanced NK cell\u2010mediated killing by regulating immune\u2010related genes","volume":"14","author":"Shin S","year":"2017","journal-title":"Cancer Genomics Proteomics"},{"key":"e_1_2_8_117_1","first-page":"1351","article-title":"The histone deacetylase inhibitor trichostatin a promotes apoptosis and antitumor immunity in glioblastoma cells","volume":"33","author":"Horing E","year":"2013","journal-title":"Anticancer Res"},{"key":"e_1_2_8_118_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404862"},{"key":"e_1_2_8_119_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-007-0402-4"},{"key":"e_1_2_8_120_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-07-5270"},{"key":"e_1_2_8_121_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2567.2007.02689.x"},{"key":"e_1_2_8_122_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-016-1900-z"},{"key":"e_1_2_8_123_1","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2015.46"},{"key":"e_1_2_8_124_1","doi-asserted-by":"publisher","DOI":"10.2217\/epi.14.69"},{"key":"e_1_2_8_125_1","doi-asserted-by":"publisher","DOI":"10.1111\/nbu.12278"}],"container-title":["Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fcncr.32041","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cncr.32041","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/cncr.32041","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cncr.32041","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:35:00Z","timestamp":1761863700000},"score":1,"resource":{"primary":{"URL":"https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/10.1002\/cncr.32041"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,6]]},"references-count":124,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,5,15]]}},"alternative-id":["10.1002\/cncr.32041"],"URL":"https:\/\/doi.org\/10.1002\/cncr.32041","archive":["Portico"],"relation":{},"ISSN":["0008-543X","1097-0142"],"issn-type":[{"value":"0008-543X","type":"print"},{"value":"1097-0142","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,6]]},"assertion":[{"value":"2018-08-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-01-25","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-03-06","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}